Acasă › Cancer ovarian › Connecticut › New Haven
Studii clinice pentru Cancer ovarian în New Haven, CT
21 studii pentru Cancer ovarian caută participanți în și în jurul orașului New Haven (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
În curs de recrutareFaza 2/3
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · La 7 mi distanță
- Smilow Cancer Hospital-Derby Care Center, Derby · La 8 mi distanță
- și încă 1
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Yale Cancer Center, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- Yale Cancer Center, New Haven
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 2
- Yale Cancer Center, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Yale University - Yale University School of Medicine, New Haven
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
În curs de recrutareFaza 2
- Yale University School of Medicine /ID# 275794, New Haven
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- Yale University, Yale Cancer Center, New Haven
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
În curs de recrutareFaza 1/2
- Yale Cancer Center, New Haven
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
În curs de recrutareFaza 3
- Yale-New Haven Hospital-Smilow Cancer Hospital at Yale-New Haven ( Site 0001), New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
În curs de recrutareFaza 1
- Normunity Investigational Site, New Haven
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
În curs de recrutareFaza 3
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
În curs de recrutareFaza 2/3
- Yale University School of Medicine, New Haven
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
În curs de recrutare
- Yale University, New Haven
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
În curs de recrutareFaza 1
- Yale University, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Yale University, Yale Cancer Center, New Haven
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
În curs de recrutareFaza 3
- Smilow Cancer Hospital at Yale- New Haven, New Haven
- Yale University School of Medicine, New Haven
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
În curs de recrutareFaza 1/2
- Yale University, Yale Cancer Center, New Haven
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
În curs de recrutareFaza 1
- Yale University, New Haven
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
În curs de recrutareFaza 2
- Smilow Cancer Hospital at Yale - New Haven, New Haven
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în New Haven
- Cancer pulmonar cu celule non-pătrate41 studii
- Cancer de sân38 studii
- Cancer (toate tipurile)33 studii
- Cancer metastatic23 studii
- Cancer pulmonar22 studii
- Carcinom cu celule scuamoase de cap și gât22 studii
- Cancer colorectal20 studii
- Cancer de prostată20 studii
- Leucemie mieloasă acută17 studii
- Tulburare de utilizare a alcoolului (AUD)17 studii
- Supradozaj cu opioide17 studii
- Cancer pancreatic16 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.